Search results for " Liv"

showing 10 items of 2456 documents

Latvijas Vēstures Institūta Žurnāls. 2014, Nr. 1 (90)

2014

Valsts kultūrkapitāla fonds

:HUMANITIES and RELIGION::History and philosophy subjects::Archaeology subjects [Research Subject Categories]Rīgas arhibīskapi - Vācu ordeņa varaskāres upuri:HUMANITIES and RELIGION::History and philosophy subjects::History subjects [Research Subject Categories]Vietējo iedzīvotāju loma Vācu ordeņa un Prūsijas bīskapiju zemes pārvaldes varas hierarhijāHierarhijas aspekti Livonijas pilsētu attiecībās viduslaikosLivonija Svētajā Romas impērijāZinātnes dzīveVēstures avotiFogtu statuss Rīgas bīskapijāPersonālijas
researchProduct

Das Buch der Güter Livlands und Oesels

1863

:HUMANITIES and RELIGION::History and philosophy subjects::History subjects::Legal history [Research Subject Categories]Livländische VerwaltungsgeschichteGüter LivlandsLauksaimniecības vēsture - LivonijaLivländische LandwirtschaftsgeschichteGüter Ösels:HUMANITIES and RELIGION::History and philosophy subjects::History subjects::Agricultural history [Research Subject Categories]Livonijas administratīvā vēstureLivonijas vēstureÖsels
researchProduct

Livländische Process-Ordnung

1701

:LAW/JURISPRUDENCE::Procedural law [Research Subject Categories]Livonijas tiesību vēstureVerfahrensrechte - LivlandLivländische ProcessordnungKriminālprocess - LivonijaCivilprocess - LivonijaTiesību vēsture - LivonijaRechtsgeschichte - LivlandLivonian LawRokrakstu kolekcija
researchProduct

Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

2021

<b><i>Introduction:</i></b> The prognosis of patients undergoing transarterial chemoembolization (TACE) is extremely variable, and a confounding factor is that TACE is often repeated several times. We retrospectively evaluated the accuracy of different prognostic scores and staging systems in estimating overall survival (OS) in patients with hepatocellular carcinoma (HCC). <b><i>Methods:</i></b> An analysis considering prognostic models as time-varying variables was performed, calculating OS from the time of TACE to the time of the subsequent treatment. Total follow-up time for each patient was therefore split into several observation times ac…

ALBI grade; Barcelona Clinic Liver Cancer; Cancer of the Liver Italian Program; ITALICA staging system; MESIAHmedicine.medical_specialtylcsh:RC254-282GastroenterologyALBI gradeBarcelona Clinic Liver CancerInternal medicineMedicineIn patientCancer of the Liver Italian ProgramITALICA staging systemRadiologic ResponseSettore MED/12 - GastroenterologiaOriginal PaperHepatologybusiness.industryProportional hazards modelConfoundingHazard ratiolcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseMESIAHOncologyHepatocellular carcinomaAkaike information criterionbusinessLiver cancer
researchProduct

Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.

2022

Funder: European Commission

ALTtype 2 diabetes mellitusROC receiving operator characteristicaspartate aminotransferaseHSDLDL low-density lipoproteinUHPLC ultrahigh-performance liquid chromatographyROCHCCNon-alcoholic steatohepatitisGCPCANASHGastroenterology2-HB 2-hydroxybutanoic acid; 3-HB 3-hydroxybutanoic acid; ALT alanine aminotransferase; AST aspartate aminotransferase; CE cholesterol ester; Cer ceramide; FFA free fatty acid; FLIP Fatty Liver Inhibition of Progression; Fibrosis; GC gas chromatography; HCC hepatocellular carcinoma; HSD honest significant difference; LC lipid cluster; LDL low-density lipoprotein; LM lipid and metabolite; LMC lipid metabolite and clinical variable; LPC lysophosphatidylcholine; Lipidomics; Mass spectrometry; Metabolomics; NAFL non-alcoholic fatty liver; NAFLD non-alcoholic fatty liver disease; NAS NASH activity score; NASH non-alcoholic steatohepatitis; NIDDK NASH-CRN National Institute of Digestive Diseases and Kidney NASH Clinical Research Network; NRR non-rejection rate; Non-alcoholic steatohepatitis; PC(O) ether PC; PC phosphatidylcholine; PCA principal component analysis; PE phosphatidylethanolamine; QTOFMS quadrupole-time-of-flight mass spectrometry; ROC receiving operator characteristic; SAF steatosis activity and fibrosis; SM sphingomyelin; T2DM type 2 diabetes mellitus; TG triacylglycerol; UHPLC ultrahigh-performance liquid chromatographySAFSAF steatosis activity and fibrosisLM lipid and metabolitehonest significant differenceHSD honest significant differenceTG triacylglycerolnon-rejection ratecholesterol esterPCPEGC gas chromatographyfree fatty acidFLIPNASH non-alcoholic steatohepatitisNIDDK NASH-CRN National Institute of Digestive Diseases and Kidney NASH Clinical Research NetworkBIOMARKERST2DMPE phosphatidylethanolamineLDLlipidNAFLDFFA free fatty acid2-HBMetabolomicsNAFL non-alcoholic fatty liverLMCphosphatidylcholineScience & TechnologySM sphingomyelinGastroenterology & HepatologyMass spectrometryactivitynutritional and metabolic diseasesT2DM type 2 diabetes mellitusACIDSreceiving operator characteristicdigestive system diseasesquadrupole-time-of-flight mass spectrometryLC lipid clusterlow-density lipoproteinNAS2-HB 2-hydroxybutanoic acidNAS NASH activity scoreQTOFMSether PCNRRSCORING SYSTEMprincipal component analysisgas chromatographyLC2-hydroxybutanoic acidPROGRESSIONAST aspartate aminotransferaseLMPC phosphatidylcholinePC(O)MARKERSUHPLCsteatosisTOOLImmunology and AllergyINSULIN-RESISTANCECerSMFatty Liver Inhibition of Progressionhepatocellular carcinoma2-HB 2-hydroxybutanoic acid NIDDK NASH-CRN National Institute of Digestive Diseases and Kidney NASH Clinical Research Network NRR non-rejection rate Non-alcoholic steatohepatitis PC(O) ether PC PC phosphatidylcholine PCA principal component analysis PE phosphatidylethanolamine QTOFMS quadrupole-time-of-flight mass spectrometry ROC receiving operator characteristic SAF steatosis activity and fibrosis SM T2DM type 2 diabetes mellitus TG triacylglycerol UHPLC ultrahigh-performance liquid chromatographyultrahigh-performance liquid chromatographyCELPC3-HBNAFLnon-alcoholic fatty liverTGtriacylglycerolNRR non-rejection rateLife Sciences & BiomedicineNAFLD non-alcoholic fatty liver diseaseFLIP Fatty Liver Inhibition of Progressionalanine aminotransferasemetaboliteCer ceramideCE cholesterol estersphingomyelinlysophosphatidylcholineand fibrosisALT alanine aminotransferaseInternal MedicineceramideNational Institute of Digestive Diseases and Kidney NASH Clinical Research NetworkAST3-HB 3-hydroxybutanoic acidQTOFMS quadrupole-time-of-flight mass spectrometryPCA principal component analysisLPC lysophosphatidylcholineHepatologynon-alcoholic fatty liver diseaseand clinical variablePC(O) ether PC3-hydroxybutanoic acidFibrosisNASH activity scoreNIDDK NASH-CRNlipid clusterlipid and metabolitephosphatidylethanolamineLipidomicsLMC lipid metabolite and clinical variableFFAHCC hepatocellular carcinomaJHEP reports : innovation in hepatology
researchProduct

Le prix des paysages périurbains

2007

L'évaluation économique du prix des paysages périurbains utilise des analyses géographiques (occupation des sols, composition paysagère, distance à des biens paysagers, paysages vus : champ de vision, objets, formes). L'article fait le point sur la littérature en matière de méthode et de résultats et présente l'estimation du prix d'attributs paysagers dans la ceinture périurbaine de Dijon.

AMENITEamenityhedonic price[SHS.GEO] Humanities and Social Sciences/Geographymodèle[ SHS.GEO ] Humanities and Social Sciences/GeographypériurbainEconomies et financesaménité0502 economics and businesszone périurbainePRIX HEDONISTE050207 economicspaysageprix hédonisteliving environmentestimation05 social sciencesattribut paysagerperiurban[SHS.GEO]Humanities and Social Sciences/Geography15. Life on landPRIX HEDONISTE;CADRE DE VIE;AMENITE;LANDSCAPE;PERIURBAN;HEDONIC PRICE;LIVING ENVIRONMENT;AMENITYlandscape[SHS.ECO]Humanities and Social Sciences/Economics and FinanceEconomies and financesméthode050202 agricultural economics & policycadre de viePRIX HEDONISTE CADRE DE VIE AMENITE LANDSCAPE PERIURBAN HEDONIC PRICE LIVING ENVIRONMENT AMENITY paysage zone périurbaineattribut paysagerestimation modèleméthode
researchProduct

Sex ratio operativa della popolazione di Paracentrotus lividus (Lam.) nell’AMP Isola di Ustica

2006

Nell’AMP ”Isola di Ustica” l'instaurazione del regime di protezione, e quindi del divieto di prelievo, ha provocato un aumento della densità del riccio edule Paracentrotus lividus (Lam.) con conseguenze negative sulle comunità algali. L’intenso pascolo di questi echinidi regolari ha infatti trasformato la fascia superficiale sommersa in un barren ground, area a bassa complessità e diversità. Una buona stima della sex ratio operativa (OSR) di P. lividus può chiarire aspetti importanti della dinamica di popolazione di questa specie ed essere di notevole aiuto in una logica di intervento gestionale. Scopo del lavoro è stato quello di valutare la OSR della popolazione di P. lividus presente nel…

AMPs Mar Mediterraneo Sex ratio Dinamica di popolazioneParacentrotus lividu
researchProduct

CLINICAL CHARACTERISTICS AND PLASMA LIPIDS IN SUBJECTS WITH FAMILIAL COMBINED HYPOLIPIDEMIA: A POOLED ANALYSIS

2013

Background. Angiopoietin-like 3 (ANGPTL3) regulates lipoprotein metabolism by modulating extracellular lipases. Loss-of function mutations in ANGPTL3 gene cause familial combined hypolipidemia (FHBL2). The mode of inheritance and hepatic and vascular consequences of FHBL2 have not been fully elucidated. To get further insights on these aspects, we re-evaluated the clinical and the biochemical characteristics of all reported cases of FHBL2. Methods and Results. One hundred fteen FHBL2 individuals carrying 13 different mutations in the ANGPTL3 gene (14 homozygotes, 8 compound heterozygotes and 93 heterozygotes) and 402 controls were considered. Carriers of 2 mutant alleles had undetectable pl…

ANGPTL3 mutations; angiopoietin-like 3; cardiovascular disease; diabetes mellitus; fatty liverSettore MED/09 - Medicina InternaCompound heterozygosityBiochemistryCohort StudiesHypobetalipoproteinemiasEndocrinologyANGPTL3cardiovascular diseaseGenotypeChildLipoproteinclinical characteristicsAged 80 and overbiologydiabetes mellituFatty liverHomozygoteLipoprotein(a)Middle AgedANGPTL3 mutationLipidsCardiovascular Diseasesdiabetes mellitusANGPTL3 Familial combined hypolipidemia LipoproteinAdultmedicine.medical_specialtyHeterozygoteANGPTL3; Familial combined hypolipidemia; clinical characteristicsAdolescentEvinacumabQD415-436Young AdultDiabetes mellitusInternal medicinemedicineHumansANGPTL3 mutationsAlleleFamilial combined hypolipidemiaAgedAngiopoietin-Like Protein 3fatty liverangiopoietin-like 3Cell Biologymedicine.diseaseEndocrinologyAngiopoietin-like ProteinsGene Expression RegulationMutationbiology.proteinPatient-Oriented and Epidemiological ResearchAngiopoietinsLipoproteinLipoprotein(a)
researchProduct

Effectiveness and safety of lomitapide in a patient with familial chylomicronemia syndrome

2020

Background: Familial chylomicronemia syndrome (FCS) is characterized by severe fasting hypertriglyceridemia, abdominal pain, and recurrent acute pancreatitis. Available triglyceride-lowering drugs are insufficient to avoid pancreatitis. Therefore, there is a significant unmet medical need for effective triglyceride-lowering drugs for patients with FCS. Case report: We report the second case of a patient with FCS and recurrent pancreatitis treated with lomitapide. Lomitapide treatment resulted in a reduction of fasting TG levels from 2897 mg/dL (32.71 mmol/L) to an average of 954 mg/dL (10.77 mmol/L) on the 30 mg lomitapide equating to a 67% reduction from baseline. After 26 months of lomita…

Abdominal painPediatricsmedicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismGastroenterology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyRecurrent pancreatitisInternal medicineFatty liverHumansMedicineProspective Studiesmedicine.diagnostic_testbusiness.industryFatty liverHypertriglyceridemiaFCSFamilial Chylomicronemiamedicine.diseaseLomitapideLomitapideAcute pancreatitisPancreatitischemistry030220 oncology & carcinogenesisLiver biopsyAcute DiseaseAcute pancreatitisPancreatitisBenzimidazolesHyperlipoproteinemia Type Ilipids (amino acids peptides and proteins)medicine.symptomCardiology and Cardiovascular MedicinebusinessFamilial chylomicronaemia syndromeAtherosclerosis
researchProduct

La casa ipertestuale. Le stanze e lo spazio-soglia

2008

Il saggio descrive i risultati di un'esperienza di seminario/workshop extracurriculare, svoltosi a Palermo nel 2005 (dal titolo: “Futura. Come abiteremo domani”). La metafora dell’ipertesto, spesso utilizzata da architetti, filosofi e urbanisti come metafora significativa per descrivere la condizione metropolitana contemporanea, risulta particolarmente efficace quale rappresentazione sintetica dell’idea di casa che abbiamo inteso indagare, per alcune sue qualità essenziali che trovano immediato riscontro nelle nuove modalità dell’abitare. All’interno del tema più generale della casa “ipertestuale”, la sperimentazione diretta dal Emanuele Palazzotto ha inteso esplorare alcune possibilità di …

Abitare contemporaneofuturo Casa IpertestualeAbitare contemporaneo; futuro Casa IpertestualeSettore ICAR/14 - Composizione Architettonica E UrbanaContemporary Living inhabiting the future Hypertextual House
researchProduct